Study registry for adults with hepatitis D infection
Part of Digestive system, Infections clinical trials.
This is a registry-based study that collects information from adults who have hepatitis D infection confirmed by a positive RNA test. It may help researchers better understand hepatitis D in real-world patients and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have hepatitis D infection confirmed by a positive test for HDV RNA
- Your test result can be provided on or before the study start date
- You can sign a written informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patient information (your health data) for adults who test positive for HDV. You may help researchers better understand HDV by allowing their team to collect and use your data.
This trial focuses on improving and standardizing how hepatitis delta is cared for in the Netherlands. To take part, you must have confirmed active hepatitis delta and be an adult.
This trial tests a drug called bulevirtide for people with chronic hepatitis B and D (HDV) co-infection. It looks at how the immune system and virus respond to treatment.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
This trial is testing treatments for people with chronic hepatitis D, a serious liver infection. If you have antibodies to the hepatitis D virus (HDV), you may be able to join and help find better ways to manage this condition.
This study uses a mobile diary app to track symptoms and quality of life for people living with hepatitis D infection. It may help researchers better understand the patient experience.
Hear when a new Hepatitis D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.